Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TISSARA: Ticagrelor vs Clopidogrel in STEMI
NCT06667349Phase 4Completed
- Sponsor
- National Institute of Cardiovascular Diseases
- Start
- Aug 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor in ST elevation myocardial infarction (STEMI) (2 cohorts), sponsored by National Institute of Cardiovascular Diseases. Primary endpoint: Incidence of Stent Thrombosis. Started Aug 2023; status: completed.
02
Drugs
ticagrelor
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06667349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06667349.